Cell culture metabolomics: Applications and future directions

Drug Discovery Today

Volumn 15, Issue 15-16, 2010, Pages 610-621

  Čuperlović Culf, Miroslava ^a,c   Barnett, David A ^b   Culf, Adrian S ^b,c   Chute, Ian ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b ATLANTIC CANCER RESEARCH INSTITUTE   (Canada)

^c MOUNT ALLISON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHANOL; PHOSPHATE BUFFERED SALINE;

CELL ASSAY; CELL CULTURE; CELL DIVISION; CELL GROWTH; CELL LINE; CHEMOMETRIC ANALYSIS; CULTURE MEDIUM; CULTURE TECHNIQUE; EXPERIMENTAL DESIGN; HETERONUCLEAR NUCLEAR MAGNETIC RESONANCE; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN FOOTPRINTING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW;

ANIMALS; CELL CULTURE TECHNIQUES; DRUG DESIGN; HUMANS; METABOLOMICS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS;

EID: 77955518663     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.06.012     Document Type: Review

References (82)

1. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genomics 2001, 2:155-168.
2. Oliver S.G., et al. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998, 16:373-378.
3. Nicholson J.K., et al. 'Metabonomics' understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
4. Beckonert O., et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2007, 2:2692-2703.
5. 1H NMR metabonomics as a prognostic and diagnostic tool. Exp. Rev. Mol. Diagn. 2007, 7:761-773.
6. Griffin J.L., Shockcor J.P. Metabolomic profiles of cancer cells. Nat. Rev. Cancer 2004, 4:551-561.
7. 1H-NMR-based metabolomics. Exp. Rev. Mol. Diagn. 2006, 6:717-731.
8. Sreekumar A., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
9. Clayton T.A., et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14728-14733.
10. 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2008, 375:356-361.
11. Soininen P., et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009, 134:1781-1785.
12. Khoo S.H.G., Al-Rubeai M. Metabolomics as a complementary tool in cell culture. Biotechnol. Appl. Biochem. 2007, 47:71-84.
13. Sellick C.A., et al. Effective quenching processes for physiologically valid metabolite profiling of suspension cultured Mammalian cells. Anal. Chem. 2009, 81:174-183.
14. Teng Q., et al. A direct cell quenching method for cell-culture based metabolomics. Metabolomics 2009, 5:199-208.
15. Duarte I.F., et al. Analytical approaches towards successful human cell metabolome studies by NMR spectroscopy. Anal. Chem. 2009, 81:5023-5032.
16. Yuan J., et al. Kinetic flux profiling for quantitation of cellular metabolic fluxes. Nat. Protoc. 2008, 3:1328-1340.
17. Ritter J.B., et al. Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: optimization using experimental design. Anal. Biochem. 2007, 373:349-369.
18. Pearson H. Nature News: meet the human metabolome. Nature 2007, 446:8.
19. Goodacre R., et al. Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics 2007, 3:231-241.
20. Snijder B., et al. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 2009, 461:520-523.
21. Begley P., et al. Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. Anal. Chem. 2009, 81:7038-7046.
22. Viant M.R., et al. International NMR-based environmental metabolomics intercomparison exercise. Environ. Sci. Technol. 2009, 43:219-225.
23. Tiziani S., et al. Metabolic profiling of drug responses in acute myeloid leukaemia cell lines. PLoS One 2009, 4:e4251.
24. Ramanathan A., et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5992-5997.
25. Meadows A.L., et al. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol. Prog. 2008, 24:334-341.
26. Sterin M., et al. Hormone sensitivity is reflected in the phospholipid profiles of breast cancer cell lines. Breast Cancer Res. Treat. 2004, 87:1-11.
27. 1H NMR of whole cells and cellular extracts. NMR Biomed. 2008, 21:809-819.
28. 31P NMR spectroscopy. NMR Biomed. 1993, 6:254-263.
29. Hartmann M., et al. Changes of the metabolism of the colon cancer cell line SW-480 under serum-free and serum-reduced growth conditions. In Vitro Cell. Dev. Biol. Anim. 2008, 44:458-463.
30. Griffin J.L., et al. Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed. 2002, 15:375-384.
31. 1H-NMR measured changes of the metabolite profile as mesenchymal stem cells differentiate to targeted fat cells in vitro: implications for non-invasive monitoring of stem cell differentiation in vivo. J. Tissue Eng. Regen. Med. 2008, 2:482-490.
32. Peet A.C., et al. 1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines. NMR Biomed. 2007, 20:692-700.
33. Borel M., et al. N-(4-iodophenyl)-N'-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice. Br. J. Cancer 2007, 96:1684-1691.
34. Morvan D., et al. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations. Magn. Reson. Med. 2003, 49:241-248.
35. Dietmair S., et al. Towards quantitative metabolomics of mammalian cells - development of a metabolite extraction protocol. Anal. Biochem. 2010, 10.1016/j.ab.2010.04.031.
36. Dettmer K., et al. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 2007, 26:51-78.
37. Griffin J.L. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol. 2003, 7:648-654.
38. Metabolomics by In Vivo NMR 2005, Wiley. R.G. Shulman, D.L. Rothman (Eds.).
39. Thrippleton M.J., et al. A fast method for the measurement of diffusion coefficients: one-dimensional DOSY. Magn. Reson. Chem. 2003, 41:441-447.
40. Lindon J.C., et al. Handbook of Metabonomics and Metabolomics 2006, Elsevier.
41. Adams R.W., et al. Reversible interactions with para-hydrogen enhance NMR sensitivity by polarization transfer. Science 2009, 323:1708-1711.
42. Fiehn O. Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry. Trends Analyt. Chem. 2008, 27:261-269.
43. Juo C.-G., et al. Liquid chromatography-mass spectrometry in metabolite profiling. Biofactors 2008, 34:159-169.
44. Guevremont R. High-field asymmetric waveform ion mobility spectrometry: a new tool for mass spectrometry. J. Chromatogr. A 2004, 1058:3-19.
45. Brown M., et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst 2009, 134:1322-1332.
46. 13C stable isotope-resolved metabolomics (SIRM). Mol. Cancer 2009, 8:41.
47. Chan E.C., et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 2009, 8:352-361.
48. Yang C., et al. Comparative metabolomics of breast cancer. Pac. Symp. Biocomput. 2007, 2007:181-192.
49. Richardson A.D., et al. Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res. Treat. 2008, 110:297-307.
50. Yang C., et al. Profiling of central metabolism in human cancer cells by 2D NMR, GC-MS analysis and isotopomer modelling. Metabolomics 2008, 4:13-29.
51. Klawitter J., et al. Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study. Br. J. Cancer 2009, 100:923-931.
52. 13C metabolomics. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4846-4851.
53. Berthon H.A., et al. 13C NMR isotopomer and computer-simulation studies of the non-oxidative pentose phosphate pathway of human erythrocytes. Biochem. J. 1993, 296:379-387.
54. Uehara T., et al. Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. Anal. Chem. 2009, 81:3836-3842.
55. Ogiso H., Taguchi R. Reversed-phase LC/MS method for polyphosphoinositide analysis: changes in molecular species levels during epidermal growth factor activation in A431 cells. Anal. Chem. 2008, 80:9226-9232.
56. Mizuno H., et al. Live-single-cell metabolomics of tryptophan and histidine metabolites in a rat basophil leeukemia cell. Anal. Sci. 2008, 24:1525-1527.
57. Akhtar S.N., et al. In vitro 1H NMR studies of RD human cell infection with Echovirus 11. NMR Biomed. 2007, 20:422-428.
58. Meadows A.L., et al. Metabolic and morphological difference between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol. Prog. 2008, 24:334-341.
59. Sterin M., et al. Hormone sensitivity is reflected in the phospholipid profiles of breast cancer cell line. Breast Cancer Res. Treat. 2004, 87:1-11.
60. Lee I.J., et al. NMR metabolomic analysis of caco-2 cell differentiation. J. Proteome Res. 2009, 8:4104-4108.
61. Trygg J., et al. Chemometrics in metabonomics. J. Proteome Res. 2007, 6:469-479.
62. Holmes E., Nicholson J.K. Human metabolic phenotyping and metabolome wide association studies. Ernst Schering Found. Symp. Proc. 2007, 4:227-249.
63. Villas-Bôas S.G., et al. Mass spectrometry in metabolome analysis. Mass Spectrom. Rev. 2005, 24:613-646.
64. Wishart D.S. Quantitative metabolomics using NMR. Trends Analyt. Chem. 2008, 27:228-237.
65. Barantin L., et al. A new method for absolute quantitation of MRS metabolites. Magn. Reson. Med. 1997, 38:179-182.
66. 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 2010, 24:788-797.
67. Patterson A.D., et al. UPLC-ESI-TOFMS based metabolomics and gene expression dynamics inspector self-organizing metabolomics maps as tools for understanding the cellular response to ionizing radiation. Anal. Chem. 2008, 80:665-674.
68. Cuperlovic-Culf M., et al. NMR metabolomic analysis of samples using fuzzy K-means clustering. Magn. Reson. Chem. 2009, 47(Suppl. 1):S96-S104.
69. Belacel, N. et al. Clustering. Statistical Bioinformatics, John Wiley & Sons (2010).
70. Cuperlovic-Culf M., et al. Determination of tumour marker genes from gene expression data. Drug Discov. Today 2005, 10:429-437.
71. Wold S., et al. PLS-regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001, 58:109-130.
72. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemometr. 2002, 16:119-128.
73. Khoo S.H.G., Al-Rubeai M. Metabolic characterization of a hyper-productive state in an antibody producing NS0 myeloma cell line. Metab. Eng. 2009, 11:199-211.
74. Van Vliet E., et al. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 2007, 29:1-12.
75. Ippolito J.E., et al. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12505-12510.
76. Miccheli A.T., et al. NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis. Biochim. Biophys. Acta 2006, 1760:1723-1731.
77. Hofmann U., et al. Identification of metabolic fluxes in hepatic cells from transient 13C labelling experiments. Biotechnol. Bioeng. 2008, 100:344-354.
78. Boros L.G., et al. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov. Today 2002, 7:364-372.
79. Cascante M., Martin S. Metabolomics and fluxomics approaches. Essays Biochem. 2008, 45:67-81.
80. Boros L.G., et al. Use of metabolic pathway flux information in targeted cancer drug design. Drug Disc. Today: Ther. Strategies 2004, 1:435-443.
81. Wishart D.S., et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007, 35(Database issue):D521-D526.
82. Akiyama K., et al. PRIMe: a Web site that assembles tools for metabolomics and transcriptomics. Silico Biol. 2008, 8:0027.